Eurointervention

Article	Citations
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity	181
Double-tap to treat paravalvular leak in high-risk annuli	148
Transcatheter left ventriculoplasty	141
In search of the origin of the acronym TAVI	132
Recanalisation of coronary chronic total occlusions	110
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry	95
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s	92
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement	82
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis	68
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation	61
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure	56
Defer-based non-stenting: a promising approach for STEMI	56
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document	49
The “road travelled”: reflections on the transformation of information exchange in a digital age	49
Hybrid coronary revascularisation: the best or the worst of both worlds?	49
   Atrial fibrillation and acute coronary syndrome 	47
One-month DAPT after acute coronary syndrome: too short or not too short?	44
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection	42
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial	41
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study	41
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve	39
Redo transcatheter mitral valve replacement in mitral annular calcification	38
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons	34
A novel robotic radiation shielding device for interventional cardiology procedures	34
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD	34

Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes	34
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis	33
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study	33
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study	32
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement	32
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial	32
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation	31
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry	30
Five-year follow-up of transcatheter tricuspid valve replacement with the EVOQUE valve	28
Antithrombotic therapy for transcatheter structural heart intervention	28
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation	27
Retrievable scaffold therapy before paclitaxel drug-coated balloon angioplasty in infrapopliteal arteries: one-year outcomes of the DEEPER OUS Study	27
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation	26
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty	26
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry	26
Cerebral embolic protection during transcatheter heart interventions	25
Shifting focus in bifurcations.	25
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons	24
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders	24
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial	23
Carbon footprint of diagnostic coronary angiography	23
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure	23
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?	22
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients	22
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome	21
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome	20
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons	19
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 	19
Transcatheter treatment of bicuspid aortic valve stenosis	18
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial	18
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation	18
TRICURE: first-in-human study of the Topaz transcatheter tricuspid heart valve system	18
The patent foramen ovale does not spontaneously close in patients aged 60	18
FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trial	18
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair	17
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions	17
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias	17
Targeting inflammation in atherosclerosis: overview, strategy and directions	16
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?	15
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation	15
Stent underexpansion in the CRUNCH registry: worth cracking?	15
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis	15
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation	14
Transcatheter aortic valve alignment: substantial progress, remaining gaps	13
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI	13
Letter: Caffeine and fractional flow reserve overestimation: a word of caution	13
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin	13
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry	13
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?	13
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry	13

PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease	13
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials	12
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis	12
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies	11
Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials	11
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons	11
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv	11
Device-related thrombus following left atrial appendage occlusion	11
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation	10
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial	10
Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA	10
Letter: Complex PCI in severe aortic stenosis: high risk, low reward?	10
Transcatheter interventions for heart failure	10
Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with	10
Skating on thin ice: searching for vulnerable plaques	9
First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation	9
A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study	9
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	9
A randomised controlled trial of the Cathpax AIR radioprotection cabin during cardiology procedures	9
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women	9
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial	9
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation	8
“Lotus root”: a novel optical coherence tomography imaging pattern in spontaneous coronary artery dissection	8
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry	8
Coronary access after transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis	8
Changes in post-PCI optimisation strategies with post-procedural FFR followed by IVUS	8
Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions	8
Temporal patterns, characteristics, and predictors of clinical outcomes in patients undergoing percutaneous coronary intervention for stent thrombosis	8
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity	7
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and	7
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement	7
Transcatheter tricuspid interventions are performed too late: pros and cons	7
Robotic-assisted percutaneous coronary intervention: the future or the past?	7
Pulmonary artery denervation – the suspense continues?	7
Reply: Beyond frame expansion: interpreting the implications of routine post-dilatation	7
Thirty years of transradial coronary interventions	7
Microaxial flow pump for high-risk PCI: are we ready for the prime time?	6
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow	6
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability	6
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial	6
New-onset or newly detected atrial fibrillation after transcatheter aortic valve implantation?	5
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike	5
Durability of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: the last missing piece?	5
Histological examination of renal nerve distribution, density, and function in humans	5
Scores and algorithms in CTO PCI: “PROGRESS” or an exercise in futility?	5
SESAME technique: septal scoring along the midline endocardium	5
Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction	5
Letter: Beyond frame expansion: interpreting the implications of routine post-dilatation	5
TAVI at 20: how a crazy idea led to a clinical revolution	5
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off	5
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club	5
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial	5
Discontinuation of the ACURATE transcatheter heart valve platform: loss or reckoning?	5
TAVI in asymptomatic patients with severe aortic stenosis: pros and cons	4
Electrosurgical laceration and stabilisation of three clip devices (ELASTA-Clip) to enable transcatheter mitral valve implantation	4
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation	4
A novel spacer for transcatheter treatment of tricuspid regurgitation	4
Stop at the yellow light spot: in vivo detection of preclinical atherosclerosis	4
Treatment of severe aortic valve regurgitation with the Trilogy TAVI system	4
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial	4
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial	4
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial	4
Consider aspirin bridging for non-cardiac surgery in patients with coronary stents treated with oral anticoagulation monotherapy	4
Cost-effectiveness of an FFR-guided strategy during STEMI – no rose without a thorn	4
Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons	4
Will the dream of “leave nothing behind” remain a utopia if we forget to optimise the systemic medical therapy?	4
Treatment of patent foramen ovale	4
The 17th expert consensus document of the European Bifurcation Club – techniques to preserve access to the side branch during stepwise provisional stenting	4
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SOR	4
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial	4
VA-ECMO in cardiogenic shock: is the road closed or open?	4
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)	4
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study	3
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle	3
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study	3
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial	3
Transcatheter aortic valve implantation of a novel system for severe pure native aortic regurgitation in a patient with an ascending aorta aneurysm	3
Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure	3
Intravascular ultrasound guidance for lower extremity arterial and venous interventions	3
Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?	3

A bench study of balloon-expandable valves for the treatment of self-expanding valve failure	3
Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease	3
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month D	3
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study	3
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial	3
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?	3
TAVI in moderate aortic stenosis and heart failure: pros and cons	3
Reply: ORBITA-2 trial design and rationale: what causes angina after PCI?	3
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!	3
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged	3
Balloon-expandable versus self-expanding stents in native coarctation of the aorta: three-year results of a randomised controlled trial 	3
A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes	3
Letter: ORBITA-2 trial design and rationale: what causes angina after PCI?	3
Low urine pH: a new marker for contrast-associated acute kidney injury?	3
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion	3